News Column

DGAP-News: SYGNIS AG: Shareholders support Management proposals at SYGNIS' AGM with overwhelming majority

July 21, 2014

DGAP-News: SYGNIS AG / Key word(s): AGM/EGM SYGNIS AG: Shareholders support Management proposals at SYGNIS' AGM with overwhelming majority 21.07.2014 / 11:30 --------------------------------------------------------------------- Press Release Shareholders support Management proposals at SYGNIS' AGM with overwhelming majority Madrid, Spain and Heidelberg, Germany, 21 July 2014 - At the Annual General Meeting (AGM) of SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) held on 17 July 2014 shareholders representing 83 percent of the capital approved all proposals of the Management with an overwhelming majority. Main decisions were related to the discharge of the members of the Supervisory and the Management Board for the past Fiscal Year, the election of new members of the Supervisory Board, as well as the creation of new authorised capital. Mr. Werner-Friedrich Knuth Schaefer has left the Supervisory Board. Dr. Cristina Garmendia MendizÁbal, Chairwoman of the Supervisory Board thanked Mr. Werner-Friedrich Knuth Schaefer for his work and efforts for SYGNIS AG. She welcomed Mrs. Maria JesÚs SabatÉs Mas as new member of the Supervisory Board. At the Annual General Meeting, Pilar de la Huerta, CEO and CFO of SYGNIS, highlighted the strategic and financial achievements during fiscal year 2013 including the completion of the restructuring measures, the launch of the first products based on SYGNIS' proprietary technology QualiPhi(R) (now renamed SensiPhi(R)) by QIAGEN and the very successful capital increase. For the current year, Mrs. de la Huerta expects the development of further products in the field of DNA amplification and sequencing and the strengthening of SYGNIS' position especially in the market for Next Generation Sequencing (NGS). You will find further information about our AGM and the detailed voting results on our website: www.sygnis.com in the Investor Relations section. For further information please contact: SYGNIS AG Pilar de la Huerta CEO/CFO Tel: +34 91 192 36 50 Email: pdelahuerta@sygnis.es About SYGNIS AG: www.sygnis.com After the merger in 2012 between X-Pol Biotech, specializing in DNA amplification and sequencing, and SYGNIS AG, listed in the German Stock Exchange (Prime Standard segment, Tick: LIO1; ISIN: DE000A1RFM03), SYGNIS' new mission is to develop and distribute technologies and products from X-Pol, which has a commercial product in the DNA amplification segment, SensiPhi(R) and is currently developing other products in the field of Next Generation Sequencing. ### Disclaimer This publication is intended for information only and constitutes neither an offer to sell nor an invitation to buy securities. Some statements included in this press release, relating neither to proven financial results nor other historical data, should be viewed as forward-looking, i.e. not definite. Such statements are mainly predictions of future results, trends, plans or goals. These statements should not be considered to be total guarantees since given their very nature they are subject to known and unknown risks and imponderability and can be affected by other factors as a consequence of which the actual results, plans and goals of SYGNIS AG may deviate greatly from the established conclusions or implied predictions contained in such statements. SYGNIS does not undertake to publicly update or revise these statements in the light of new information or future results or for any other reason.### End of Corporate News --------------------------------------------------------------------- 21.07.2014 Dissemination of a Corporate News, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: SYGNIS AG Im Neuenheimer Feld 515 69120 Heidelberg Germany Phone: 06221 454-6 Fax: 06221 454-700 E-mail: contact@sygnis.de Internet: www.sygnis.de ISIN: DE000A1RFM03 WKN: A1RFM0 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, DÜsseldorf, Hamburg, MÜnchen, Stuttgart End of News DGAP News-Service --------------------------------------------------------------------- 278610 21.07.2014


For more stories on investments and markets, please see HispanicBusiness' Finance Channel



Source: DGAP Corporate News


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters